Page 15 - ஆன்டிபாடி சேர்க்கை பெறுகிறது நல்ல முடிவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆன்டிபாடி சேர்க்கை பெறுகிறது நல்ல முடிவுகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆன்டிபாடி சேர்க்கை பெறுகிறது நல்ல முடிவுகள் Today - Breaking & Trending Today

Mild cases of COVID-19 provide lasting antibody protection, shows study

Mild cases of COVID-19 provide lasting antibody protection, shows study
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.
The findings, published May 24 in the journal
Nature, suggest that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.
Last fall, there were reports that antibodies wane quickly after infection with the virus that causes COVID-19, and mainstream media interpreted that to mean that immunity was not long-lived. But that s a misinterpretation of the data. It s normal for antibody levels to go down after acute infection, but they don t go down to zero; they plateau. Here, we found ....

Jane Ohalloran , Ali Ellebedy , Iskra Pusic , Jackson Turner , Rachel Presti , Emily Henderson , Washington University School Of Medicine , Washington University School , Study Senior Author , Associate Professor , Janeo Halloran , Bone Marrow , Immune Response , ஜேன் ஓஹள்லோரன் , ஜாக்சன் டர்னர் , ரேச்சல் பிரெஸ்த்ி , எமிலி ஹென்டர்சன் , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , வாஷிங்டன் பல்கலைக்கழகம் பள்ளி , படிப்பு மூத்தவர் நூலாசிரியர் , இணை ப்ரொஃபெஸர் ,

Welcome To IANS Live - NATION - Dispovan owner to urge DRDO for new name of Covid anti-body kit

Photo Credit: IANS
IANSLive
Chennai, May 22 (IANS) With the 35 years old Rs 400 crore medical syringes brand Dispovan and the Defence Research Development Organisation s (DRDO) Dipcovan - coronavirus antibody detection kit - sounding similar, Hindustan Syringes & Medical Devices Ltd will request the defence lab to have a different brand name, said a top company official.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter. ....

India General , Tamil Nadu , Hindustan Syringes Medical Devices Ltd , News Service , India Private , Defence Research Development Organisation , Hindustan Syringes , Medical Devices Ltd , All Rights , Medi Cal , இந்தியா ஜநரல் , தமிழ் நாடு , செய்தி சேவை , இந்தியா ப்ரைவேட் , பாதுகாப்பு ஆராய்ச்சி வளர்ச்சி ஆர்கநைஸேஶந் , மருத்துவ சாதனங்கள் லிமிடெட் , அனைத்தும் உரிமைகள் , மேதி கலோரி ,

Welcome To IANS Live - LatestNews - Electrochemical ELISA: Novel test for total Covid antibody concentration

The novelty of the technology is based on the measurement of ....

New Delhi , News Service , India Private , All Rights , புதியது டெல்ஹி , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Study finds 96 per cent of COVID-19 patients have antibodies year after recovery

Study finds 96 per cent of COVID-19 patients have antibodies year after recovery
SECTIONS
Last Updated: May 22, 2021, 04:29 PM IST
Share
Synopsis
The study looked at results from 250 people aged 21-78 who tested positive for the virus between February and April last year and found that those COVID-19 patients who showed more severe symptoms all had antibodies in the following year, while 97 per cent of those with mild or no symptoms had antibodies in the first six months after being ill.
ANI
A study by Japan s Yokohama City University showed that 96 per cent of people previously infected with COVID-19 still had antibodies a year after recovery, Kyodo News Agency reported. ....

South Africa , United Kingdom , South African , Kyodo News Agency , Japan Yokohama City University , Yokohama City University , Covid 19 , ஒன்றுபட்டது கிஂக்டம் , ஜப்பான் யோகோகாமா நகரம் பல்கலைக்கழகம் , யோகோகாமா நகரம் பல்கலைக்கழகம் ,

Welcome To IANS Live - SCIENCE - Electrochemical ELISA: Novel test for total Covid antibody concentration

Photo Credit: IANS
IANSLive
New Delhi, May 22 (IANS) In a first of its kind technology, a test would now help rapid and accurate estimation of total antibody concentration of Covid-19 in clinical samples.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 22-May-2021 ....

New Delhi , News Service , India Private , All Rights , புதியது டெல்ஹி , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,